Dashboard
My Portfolio
Backtest
New
Portfolios
Investors
Analysts
Community
Calendars
Economic Calendar
Dividend Calendar
Earnings Calendar
Splits Calendar
IPO Calendar
Markets
Stocks
Indices
Forex
Crypto
Commodities
News
Sign Up
Sign In
Your search results will appear here.
Light Mode
Dark Mode
Sign Up
Sign In
Medipal Holdings Corp (7459)
Market Open
6 Oct, 06:00 AM
JPX
All
(5)
DE
(3)
JP
(1)
US
(1)
JPX
Primary
XMUN
XDUS
XFRA
OTC GREY
¥
2,956.
50
+15.5
+0.527%
¥
558.28B
Market Cap
13.58
P/E Ratio
0.4%
Div Yield
325,900
Volume
0
Eps
¥
2,941
Previous Close
Watching
Watch
Add Transaction
Day Range
2,927.5
2,965
Year Range
2,456.5
3,182
Want to track
7459
and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
Get Started For Free
Overview
Dividends
Earnings
Statistics
Historical Data
Medipal Holdings Corp (7459) Statistics
Valuation metrics
Market Cap
558.28B
Enterprise value
357.88B
Trailing P/E (ttm)
13
Forward P/E
16.07
PEG ratio
0.83
Price/Sales (ttm)
0.16
Price/Book (mrq)
0.93
Enterprise Value/Revenue
0.09
Enterprise Value/EBITDA
3.41
Overview
Shares outstanding
205.34M
Float
178.38M
Shares short
-
% Held by insiders
0.09%
% Held by institutions
0.4%
Average volume (10 days)
493.92K
Average volume (90 days)
505.57K
Price summary
52-Week low
2,456.5
52-Week high
3,182
Beta
-
50-Day moving average
2,941.32
200-Day moving average
2,820.21
Dividends and splits
Forward annual dividend rate
64
Forward annual dividend yield
0.023%
Trailing annual dividend rate
78
Trailing annual dividend yield
0.0264%
5-Year annual dividend yield
2.31%
Payout ratio
0.33
Dividend Date
29 Sep 2026
Ex-Dividend Date
29 Sep 2026
Last split factor
-
Last split Date
-
Financials
Fiscal year
Fiscal year ends
31 Mar 2025
Most recent quarter (mrq)
30 Jun 2025
Profitability
Profit margin
0.01%
Operating margin
0.01%
Operational effectiveness
Return on assets
0.02%
Return on equity
0.07%
Income Statement
Revenue (ttm)
3.78T
Revenue per share (ttm)
18,865.25
Quarterly revenue growth (yoy)
0.03%
Gross profit (ttm)
260.56B
EBITDA
83.68B
Net income to common (ttm)
41.46B
Diluted EPS (ttm)
227.62
Quarterly earnings growth (yoy)
0.06%
Balance Sheet
Total cash (mrq)
275.87B
Total cash per share (mrq)
1,416.34
Total debt (mrq)
-
Total Debt/Equity (mrq)
0.07
Current ratio (mrq)
1.29%
Book value per share (mrq)
3,867.71
Cash Flow
Cash flow statement
65.21B
Levered free cash flow (LFCF)
40.28B